Stage II testicular seminoma: patterns of recurrence and outcome of treatment
- PMID: 15149748
- DOI: 10.1016/j.eururo.2004.01.020
Stage II testicular seminoma: patterns of recurrence and outcome of treatment
Abstract
Objectives: To review treatment outcome and patterns of failure for patients with stage II testicular seminoma and to identify prognostic factors for relapse.
Methods: From 1981 to 1999, 126 men with stage II seminoma were treated at Princess Margaret Hospital. Of these, 95 were treated with radiotherapy (RT) and 31 with chemotherapy (ChT). Patient and tumour characteristics were analyzed for prognostic significance for subsequent relapse.
Results: At median follow-up of 8.5 years, the 5- and 10-year overall survival were both 93%, the 5- and 10-year cause-specific survival were both 94% and the 5- and 10-year relapse-free rates were both 85%. Patients with stage IIA and IIB disease treated with RT and stage IIB treated with chemotherapy had 5-year relapse-free rates of 91.7%, 89.7% and 83.3%, respectively. Seventeen percent of patients treated with radiotherapy and 6% of those treated with chemotherapy have relapsed. Of the RT patients the commonest sites of relapse were left supraclavicular fossa, lung/mediastinum, bone, para-aortics and liver; nine patients had a solitary site of relapse. Two patients treated with chemotherapy had recurrence in the para-aortic and iliac nodes. For RT patients, larger primary tumour size was associated with a reduction in relapse rate. Age, rete testis invasion and lymphovascular invasion were found not to be of prognostic significance.
Conclusions: In stage IIA/B seminoma, radiotherapy continues to provide excellent results, as the majority of patients will be cured with this treatment alone. Chemotherapy is the treatment of choice for stage IIC seminoma.
Similar articles
-
Management of Stage II testicular seminoma over a period of 40 years.Urol Oncol. 2009 Sep-Oct;27(5):534-8. doi: 10.1016/j.urolonc.2008.07.034. Epub 2008 Oct 10. Urol Oncol. 2009. PMID: 18848787
-
Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.Urology. 2006 Mar;67(3):594-8. doi: 10.1016/j.urology.2005.09.050. Urology. 2006. PMID: 16527585
-
Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.J Urol. 1997 May;157(5):1705-9; discussion 1709-10. J Urol. 1997. PMID: 9112510
-
[Treatment options in early-stage testicular seminoma. Review of the literature with initial results of a prospective multicenter study on radiotherapy of clinical-stage I, IIA and IIB seminomas].Strahlenther Onkol. 1995 Mar;171(3):125-39. Strahlenther Onkol. 1995. PMID: 7709330 Review. German.
-
Testicular seminoma: a failure analysis and literature review.Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):89-97. doi: 10.1016/0360-3016(95)00069-B. Int J Radiat Oncol Biol Phys. 1995. PMID: 7642436 Review.
Cited by
-
Advances in radiation therapy for testicular seminoma.World J Urol. 2023 Dec;41(12):3895-3903. doi: 10.1007/s00345-023-04674-8. Epub 2023 Nov 18. World J Urol. 2023. PMID: 37979002 Review.
-
Clinical dilemmas in local and regional testis cancer.Can Urol Assoc J. 2021 Jan;15(1):E58-E64. doi: 10.5489/cuaj.6913. Can Urol Assoc J. 2021. PMID: 33007187 Free PMC article. Review.
-
Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II A/B Seminomas: A Systematic Review and Meta-Analysis.Int Braz J Urol. 2024 Jul-Aug;50(4):415-432. doi: 10.1590/S1677-5538.IBJU.2024.0134. Int Braz J Urol. 2024. PMID: 38701185 Free PMC article.
-
Stage II Seminoma: Is There Something New on the Horizon?Eur Urol Open Sci. 2023 Jan 30;49:78-79. doi: 10.1016/j.euros.2023.01.007. eCollection 2023 Mar. Eur Urol Open Sci. 2023. PMID: 36793749 Free PMC article. No abstract available.
-
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse.Br J Cancer. 2008 Jun 17;98(12):1894-902. doi: 10.1038/sj.bjc.6604280. Br J Cancer. 2008. PMID: 18542063 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical